- Infectious Diseases Therapeutics
- cancer therapeutics
- Dermatology therapeutics
- Ophthalmology therapeutics
- Hematology Therapeutics
- Gastrointestinal therapeutics
- Women's Health therapeutics
- Dental Therapeutics
- Neurology therapeutics
- Respiratory therapeutics
- Diabetes Therapeutics
- Men's Health therapeutics
- Cardiovascular therapeutics
- Central Nervous System (CNS) therapeutics
- Urology therapeutics
- Kidney
- Sexually Transmitted Diseases Therapeutics
- Metabolic therapeutics therapeutics
- Pulmonary therapeutics
- Orthopedic therapeutics
- Arthritis therapeutics
- Oral Therapeutics
- Allergy therapeutics
- ENT Therapeutics
- Radiology therapeutics
- Hiv/Aids Therapeutics
Therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... view of the Grass Pollen Allergy (Immunology) pipeline landscape.
Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions, such as hives, redness or swelling, ......" | 29-Apr-2022 | $2000 | |
Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... , 2022, provides an overview of the Bone Marrow Transplant Rejection (Immunology) pipeline landscape.
Bone marrow transplant rejection is a complication that can occur after a stem cell or bone marrow transplant. The newly transplanted d......" | 29-Apr-2022 | $2500 | |
Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... iasis (Infectious Disease) pipeline landscape.
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy sk......" | 29-Apr-2022 | $2000 | |
African Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... n overview of the African Trypanosomiasis (Infectious Disease) pipeline landscape.
African trypanosomiasis (also known as African sleeping sickness) is a parasitic infection caused by a species of parasite, Trypanosoma brucei, which is t......" | 29-Apr-2022 | $2000 | |
Severe Acute Respiratory Syndrome (SARS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... s In Development, 2022, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape.
Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection cau......" | 29-Apr-2022 | $2000 | |
Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Genital Herpes (Infectious Disease) pipeline landscape.
Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused by the herpes simplex virus (HSV). Symptoms include decreased app......" | 29-Apr-2022 | $2000 | |
Influenza A Virus, H3N2 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Drugs In Development, 2022, provides an overview of the Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) pipeline landscape.
H3N2 infections are caused by variant H3N2 virus which is an influenza virus. Symptoms include co......" | 29-Apr-2022 | $2000 | |
Diabetic Nephropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... view of the Diabetic Nephropathy (Metabolic Disorders) pipeline landscape.
Diabetic nephropathy is the damage to the kidney occurring due to diabetes. It is characterized by albuminuria, reduction in glomerular filtration rate and high b......" | 29-Apr-2022 | $2000 | |
Dyslipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ipidemia (Metabolic Disorders) pipeline landscape.
Dyslipidemia is defined as elevation of the total cholesterol, the "bad" low-density lipoprotein (LDL) cholesterol and the triglyceride concentrations, and a decrease in the "good" high-......" | 29-Apr-2022 | $2500 | |
Periodontitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... riodontitis (Mouth And Dental Disorders) pipeline landscape.
Periodontitis is a gum infection that damages the soft tissue and destroys the bone that supports teeth. Signs and symptoms of periodontitis include swollen gums, bright red or......" | 29-Apr-2022 | $2000 | |
|